The phosphorylation of the androgen receptor by TFIIH directs the ubiquitin/proteasome process-Reference-Cited by-同舟云学术

The phosphorylation of the androgen receptor by TFIIH directs the ubiquitin/proteasome process

Published:2010-12-14 Issue:3 Volume:30 Page:468-479
ISSN:0261-4189
Container-title:The EMBO Journal
language:en
Short-container-title:

Author:

Chymkowitch Pierre¹,Le May Nicolas¹,Charneau Pierre²,Compe Emmanuel¹,Egly Jean-Marc¹

Affiliation:

1. Institut de Génétique et de Biologie Moléculaire et Cellulaire, Centre National de la Recherche Scientifique, INSERM, Université de Strasbourg; Illkirch cedex France

2. Département de Virologie Moléculaire et Vectorologie, Institut Pasteur; Paris France

Publisher

Wiley

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,Molecular Biology,General Neuroscience

Reference58 articles.

1. CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model;Adachi;J Neurosci,2007

2. AR, the cell cycle, and prostate cancer;Balk;Nucl Recept Signal,2008

3. The proteasome: paradigm of a self-compartmentalizing protease;Baumeister;Cell,1998

4. Analysis of mutations in the XPD gene in Italian patients with trichothiodystrophy: site of mutation correlates with repair deficiency, but gene dosage appears to determine clinical severity;Botta;Am J Hum Genet,1998

5. Protein kinases and the proteasome join in the combinatorial control of transcription by nuclear retinoic acid receptors;Bour;Trends Cell Biol,2007

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of bivalent small molecule degraders of cyclin-dependent kinase 7 (CDK7);European Journal of Medicinal Chemistry;2024-10

2. Enzalutamide inhibits PEX10 function and sensitizes prostate cancer cells to ROS activators;Cell Death & Disease;2024-08-03

3. Androgen receptor post-translational modifications and their implications for pathology;Biochemical Society Transactions;2024-07-03

4. PROTACs targeting androgen receptor signaling: Potential therapeutic agents for castration-resistant prostate cancer;Pharmacological Research;2024-07

5. A plasma membrane–associated form of the androgen receptor enhances nuclear androgen signaling in osteoblasts and prostate cancer cells;Science Signaling;2024-01-30